AP-768
780763-95-3
|
ap-1-(9-fluorenyl)-2-(1-methylethenyl)naphthalene
134864-90-7
|
AP-III-a4
1177827-73-4
|
AP-1/NF-κB activation inhibitor 1
188936-12-1
|
AP-18
55224-94-7
|
AP C5
2234272-10-5
|
AP-III-a4 hydrochloride
2070014-95-6
|
AP 20187
195514-80-8
|
AP 1903
195514-63-7
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-{[6-(morpholin-4-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-3-yl]methyl}benzamide
689770-57-8
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
N-((1-(benzo[d]oxazol-2-yl)pyrrolidin-2-yl)methyl)-2-(naphthalen-1-yl)acetamide
1788533-91-4
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
(S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulphonyl)-eth-2-ylamine N-acetyl-L-leucine salt
1382429-55-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
